Evaluating the effect of whey enriched drink on the nutritional status of patients with chronic obstructive pulmonary disease

Study of the effect of fortified whey drink with Vitamin C and Magnesium on nutritional status, quality of life, strength of muscle, oxidative stress, inflammation and pulmonary status in chronic obstructive pulmonary disease patients.

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20161119030975N2

Enrollment

Registered

2018-12-29

Start date

2018-09-23

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary diseases. Chronic obstructive pulmonary disease, unspecified

Interventions

Intervention 1: intervention group: fortified whey drink with magnesium and vitamin C and dietary recommendation. Intervention 2: Control group: dietary recommendation.

Eligibility

Sex/Gender

Male

Age

50 Years to No maximum

Inclusion criteria

Inclusion criteria: Men over 50 years old Chronic Obstructive Pulmonary Disease (COPD) disease in moderate and severe stages based on spirometry and Forced Expiratory Volume 1 (FEV1) index at least 6 months after diagnose of the moderate stage of disease. being malnourished based on fat free mass index (FFMI)

Exclusion criteria

Exclusion criteria: History of any acute inflammatory, infectious, liver, kidney, rheumatoid arthritis, heart diseases and cancer consumption of antioxidant (vitamin E, C, ...) and protein supplements

Design outcomes

Primary

Measure	Time frame
Inflammation. Timepoint: The First and End of the study. Method of measurement: Measuring Interleukin-6 and Tumor Necrosis Factor Alfa.	—

Secondary

Measure	Time frame
Malnutrition. Timepoint: The First and End of the study. Method of measurement: FFMI.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAfsane Ahmadi

Shiraz University of Medical Sciences

ahmadia@sums.ac.ir+98 71 3725 1005

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026